ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 310 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 0.98% of the total position.
      46Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 25,400 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 3.4% of the total position.
      68Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 35,960 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 3.15% of the total position.
      270Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 74,420 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 1.53% of the total position.
      282Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 35,473 shares, the number of shares held decreased 85.03% compared to the previous period and now represents 0.091% of the total position.
      156Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 530 shares, the number of shares held decreased 1.15% compared to the previous period and now represents 1.36% of the total position.
      42Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 25,670 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 2.77% of the total position.
      188Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 26,880 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 5.04% of the total position.
      124Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 28,862 shares, the number of shares held decreased 1.35% compared to the previous period and now represents 8.86% of the total position.
      91Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 2,820 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 4.11% of the total position.
      155Comment
      Report
     
     
     
     

    Most Discussed